Legal Representation
Attorney
Rachelle Dubow, Esq.
USPTO Deadlines
Next Deadline
177 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
May 07, 2026
Extension Available
Until May 07, 2025
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 19, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 19, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 21, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 20, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Feb 20, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 1, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 1, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 7, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 21, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 31, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 30, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 3, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal health, gastrointestinal dysbiosis and systemic illnesses associated with gastrointestinal dysbiosis, gastrointestinal disorders and systemic illnesses associated with gastrointestinal disorders, gastrointestinal diseases and systemic illnesses associated with gastrointestinal diseases, gastrointestinal infections and systemic illnesses associated with gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; oncolytic viral therapies; biological therapies for use in the treatment of cancer and tumors
Additional Information
Design Mark
The mark consists of a design of interlocking polygons with a dot in the middle.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005